Gujarat Alkalies sets a Rs 10,000 crore revenue target
Gujarat Alkalies and Chemicals' investor presentation for the year ended March 2026 is built around Project Ahvaan, a transformation programme run with A.T. Kearney as strategic partner since April 2025, targeting revenue of Rs 10,000 crore-plus and an EBITDA margin above 20 per cent by FY31 — a two-to-three-fold aspiration over five years. FY26 delivered revenue of Rs 4,474 crore (up from Rs 4,165 crore), EBITDA of Rs 522 crore with margin up 0.8 percentage points to 11.7 per cent, and overall sales volume up 7 per cent, including roughly 10 per cent growth in caustic sales on exports and alumina-sector demand.
The number the free layer does not tell you is the bottom line: PAT was just Rs 21 crore on that Rs 4,474 crore top line — barely above break-even and a fraction of EBITDA, though a recovery from the FY24 loss.
Why it matters
That gap between operating and net performance is the real case for Ahvaan. The pipeline is concrete: a Rs 600-650 crore board-approved near-term capex programme, nine projects underway with chlorotoluenes (30,000 TPA, Dahej) already commissioned and three more due between October 2026 and January 2027.
The details
Plus three newly board-approved projects — caustic soda lye revamp and caustic potash expansion at Vadodara (November 2028), food-grade phosphoric acid (December 2028) and electronic-grade hydrogen peroxide (January 2028). Rs 30 crore of FY27 digital spending is budgeted against a claimed Rs 50 crore of value — a ratio worth watching.
Who is affected
Gujarat Alkalies faces the challenge of converting its operating improvements into net profit growth, given PAT remains barely above break-even despite EBITDA gains.
Downstream buyers of caustic soda, chlorotoluenes and the company's new specialty products stand to benefit from the expanding project pipeline through FY31.
What's next
Watch the commissioning of the three additional chlorotoluenes-related projects due between October 2026 and January 2027, alongside the newly approved Vadodara, phosphoric acid and hydrogen peroxide projects through 2028.
Continued monitoring of the PAT-to-EBITDA gap will indicate whether Project Ahvaan is successfully bridging operating performance into bottom-line results.
For more such stories, go to https://indianpetrochem.com










